Tango Therapeutics (TNGX) EPS (Diluted) (QoQ) (2021 - 2026)

Tango Therapeutics (TNGX) EPS (Diluted) (QoQ) (2021 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Tango Therapeutics 3.94 Bn 3.78 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2026 4.96%
Dec 31, 2025 -347.34%
Sep 30, 2025 138.37%
Jun 30, 2025 2.78%
Mar 31, 2025 -4.82%
Dec 31, 2024 -28.30%
Sep 30, 2024 -13.95%
Jun 30, 2024 32.70%
Mar 31, 2024 -7.87%
Dec 31, 2023 -41.62%
Sep 30, 2023 2.29%
Jun 30, 2023 26.06%
Mar 31, 2023 4.18%
Dec 31, 2022 -0.28%
Sep 30, 2022 -16.79%
Jun 30, 2022 1.58%
Mar 31, 2022 19.00%
Dec 31, 2021 -27.13%
Sep 30, 2021 -201.55%